Viracta(VIRX) - 2021 Q1 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 Commission File Number 000-51531 VIRACTA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 94-3295878 (State or other jurisdiction of incorporation) 2533 S. Coast Hwy. 101, Suite 210 Cardiff, California 92007 (Address of principal executive offices) ...